Trailing-twelve-month (TTM) net income is $1.59 Billion with a year-over-year change of (28.96%). Net income represents the company's bottom line profit after all expenses, taxes, and interest.
Reported quarterly net income; no daily interpolation. Q2 FY2026 (2026-06-30): $573.00M.
Net Income growth vs the same fiscal quarter in the prior fiscal year, last 18 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-09-26T00:15:46.996Z. Historical observations retain their original dates. Historical series through 2026-09-11.
$1.59B
$1.59 Billion
(28.96%)
vs. $2.24B a year ago (TTM)
(31.53%)
5 Year compound annual growth rate
1 Year
(28.96%)
3 Year
(4.57%)
5 Year
(31.53%)
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Net Income | YoY Change | % Change |
|---|---|---|---|
| 2025 | $2.08B | +$91.00M | +4.57% |
| 2024 | $1.99B | +$425.00M | +27.10% |
| 2023 | $1.57B | ($348.00M) | (18.16%) |
| 2022 | $1.92B | ($331.00M) | (14.73%) |
| 2021 | $2.25B | ($11.60B) | (83.77%) |
| 2020 |
TTM Growth
(28.96%)
3-Year CAGR
(4.57%)
5-Year CAGR
(31.53%)
Unrounded diluted TTM EPS / FMP quote price × 100 Quote observation: 2026-09-26T00:15:46.996Z. Historical observations retain their original dates. Historical series through 2026-09-11.
| $13.85B |
| +$12.32B |
| +808.53% |
